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Background
•  Breakthrough pain, also referred to as a pain flare, has
been defined as “a transitory increase in pain to greater
than moderate intensity, which occurs on a baseline pain of
moderate intensity or less in a patient receiving chronic
opioid therapy”1
•  Limited research has been published to demonstrate
the economic impact of pain flares in terms of direct
and indirect costs
1. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence, and characteristics. Pain 1990;41:273-81.
Objectives
• Primary: To capture healthcare resource consumption
and work loss in a population of patients with chronic
pain who have pain flares from one or more of the
following non-cancer conditions:
–  Musculoskeletal problems (back, knee, shoulder,
neck, and other areas)
–  Rheumatological diseases (arthritis, lupus, and
others)
–  Chronic headache
–  Sickle cell anemia
•  Secondary:  To explore the relationship between
anxiety, depression, and pain in this population
Study Design
•  A 3-month prospective, observational study of
outpatients from a large tertiary U.S. medical center
Methods 
Eligibility Criteria
•  Inclusions
–  Patients with chronic pain meeting the following
definition: "Chronic pain is pain that continues a
month or more beyond the usual recovery period for an
injury or illness or that goes on for months or years due
to a chronic condition.  The pain is usually not constant,
but can interfere with daily life at all levels."2
–  Age ≥18 years 
•  Exclusions
–  Patients who were not able to communicate in
English sufficiently well to complete the required
follow-up
–  Patients deemed to be inappropriate for
participation by their physician
2. American Chronic Pain Association. Definition of Chronic Pain. 
Available at: http://www.theacpa.org
Data Collection
•  Participants were recruited through Jefferson
University Physicians’ practices
–  Jefferson Pain Center
–  Rheumatology
–  Hematology (sickle cell)
–  Neurology
•  Data collection tools:
1.  Patient diary where healthcare utilization and work
loss were captured each day for 7 consecutive days
upon study entry
2.  Monthly patient survey at months 1, 2, and 3 to
capture healthcare utilization, work loss, changes to
employment, and/or changes in treatment 
Study Measures
•  Patient demographics
•  Pain score (10 point scale)
•  Sleep quality (Pittsburgh Sleep Quality Index)*
•  Quality of life (SF-12, v2)*
•  Pain Flare Definitions Questionaire*
•  Satisfaction with pain treatment (Pain Flare Treatment
Satisfaction Questionnaire)*
•  Healthcare utilization due to pain flare(s) or pain
treatments:
–  Hospitalizations
–  Outpatient medical visits
–  Phone calls to physician office
–  Emergency room visits
–  Pain medications
–  Alternative treatments for pain
•  Work productivity loss due to pain flares or pain
treatments (Health-Related Productivity Questionnaire-
Diary)
–  Hours of work missed (absenteeism)
–  Impact on work output (presenteeism)
–  Hours of work missed at home (“around the house”)
*Results pertaining to these measures are beyond the scope of this abstract
Analysis
•  Examined direct medical costs and work productivity by
pain source, gender, ethnicity, occupation/employment
status, and age
–  Results presented herein are limited to diary findings
from the first 161 enrollees (data collection is
ongoing)
–  Breakthrough pain was defined as 1 or more pain
flares during the diary period
•  This analysis was not limited to patients receiving
opioids due to small sample size
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from Cephalon, Inc.
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Demographics
A total of 161 participants completed the diary. Most were female
(79%), caucasian (68%), and experienced at least 1 pain flare during
the diary week (88%)
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Pain Flares During Diary Week
The cohort experienced a total of 2559 pain flares (mean per patient per week=18.1)
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The mean pain levels were 5.3 for headache, 5.1 for rheumatological diseases, 6.8 for
musculoskeleletal problems, 6.1 for sickle cell anemia, and 6.5 for those with 2 or more
painful conditions
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Anxiety and Depression
Anxiety and depression were noted to be prevalent (23% reported anxiety, 25% reported
depression, 16% reported both)
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Enrollment By Pain Source (n=141)
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Most Commonly Reported Prescription
Medications for Pain (n=141)*
21.831Relaxation Technique
40.858Prayer
20.429Talked to Someone
7.110Herbal Remedies
6.49Creative Technique (art or music therapy)
4.36Acupuncture
16.924Psychological Counseling
11.316TENS*
20.429Epidural
20.429Physical Therapy
38.054Massage
42.260Exercise
60.586Hot or Cold Packs
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%nMethod
Alternative Methods Used to Relieve and/or 
Cope with Pain (at baseline; n=141)
* Pain scores based on 10-point scale with 0 described as “No Pain” and 10 described as the “Worst Pain Imaginable”
* Participants were asked to report which medical conditions they had “based on a diagnosis by a medical doctor.”
*p=0.035 for depression; **p=0.05 for both anxiety and depression
*Figure shows prescription pain medications taken by at least 5% of participants, at baseline
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During the diary week, pain flares resulted in 8 hospitalizations, 9 emergency room visits,
30 outpatient medical visits, and 24 calls to physician offices
Healthcare Resource Utilization Due to Pain 
Flares During Diary Week, by Pain Source (n=142) 
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Work Productivity: Missed Hours
During the diary week, participants missed a total of 191 work hours and 905.3 hours
of work “around the house” due to pain flares.
Conclusions
•  Patients with chronic non-cancer pain frequently
consume healthcare services to address pain flares
•  Pain flares result in lost work time  
•  Relationship between treatment and economic outcomes
(resource utilization and productivity), and the added
burden of anxiety and depression in this population
should be further examined  
Limitations
•  Most participants experienced pain flares during the
diary week, which precluded group testing between the
pain flare vs. no pain flare groups
•  Participants appear to have significant and persistent
pain, limiting generalizability
•  Analysis reflects only utilization, not costs
*Transcutaneous Electrical Nerve Stimulation
